SM can down-regulate the abnormally elevated oncogene LIF in liver cancer tissue and be used to treat liver cancer by inducing autophagy and apoptosis through the LIF/miR192-5p/CyR61/Akt axis. This evidence concerns the gene AKT1 and liver cancer.